Becton, Dickinson and Company (BDX) received an order from the Biomedical Advanced Research and Development Authority (BARDA) of the U.S. Department of Health and Human Services (HHS) for the purchase of syringes and needles, sharps collectors and alcohol swabs for use in national flu pandemic preparedness efforts. The order, worth approximately $52 million, is effective through March 2010.

The new contract is part of the company’s effort to protect Americans from the H1N1 influenza virus, commonly known as “swine flu.” Becton is also in constant touch with governments and vaccine companies across the globe to meet their needs during the flu season.

We think that the new contract will boost Becton’s top-line. This will also add to the company’s contribution to social welfare. Becton, Dickinson and Co. develops, manufactures and markets medical devices, supplies, laboratory equipment and diagnostic products globally. The company is a world leader in safety needle products.

Becton competes with players like Baxter International (BAX), Johnson & Johnson (JNJ) and Abbott Laboratories (ABT), all of which have large resources.

However, we believe that the company’s sound business model and product line should weather the current economic turbulence, and is capable of withstanding competitive pressure.

Based on the company’s performance in the third quarter of fiscal 2009, we have a Neutral recommendation on Becton stock.

Zacks Investment Research
View original at: Zacks.com News Feed

1. (GD) General Dynamics Bags $100 Million Army OrderGeneral Dynamics (GD) recently said that its unit, General Dynamics Armament and Technical Products, has...
2. (JEC) Strong Orders Buoy Jacobs – $1.1 million 3-year task order from Marine Corps SystemsYesterday, Jacobs Engineering Group Inc. (JEC) received a $215 million contract for delivering technical consultancy...
3. (BDX) Becton, Dickinson and Company – Growth And Income – Zacks Rank BuyBecton, Dickinson and Company (BDX) keeps seeing bullish forecasts on strong fundamentals as the company...
4. (BDX) Becton Dickinson and Company – Growth And Income – Zacks Rank BuyBecton, Dickinson and Company (BDX) continues to see bullish forecasts from Wall Street. Analysts are...
5. (BDX) Becton, Dickinson and Company – offers an industry-leading yield of 2%Becton, Dickinson and Company (BDX) recently declared a quarterly dividend of 33 cents per share,...
6. (BDX) Becton, Dickinson and Company – return on equity (ROE) of 23%, exceeding the industry average of 17%Becton, Dickinson and Company (BDX) offers a return on equity of 23%, exceeding the industry...

Search Posts by Tag: Abbott Laboratories | ABT | BAX | Baxter International | BDX | Becton | Dickinson And Company | Harte-Hanks Inc. | HHS | JNJ | Johnson & Johnson | Healthcare | Medical Instruments & Supplies

RSS Feeds by Tag: Abbott Laboratories | ABT | BAX | Baxter International | BDX | Becton | Dickinson And Company | Harte-Hanks Inc. | HHS | JNJ | Johnson & Johnson | Healthcare | Medical Instruments & Supplies |

Other Posts by: vitalstocks | RSS Feed for this author